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A B S T R A C T
Introduction: One-year mortality after hip fracture may exceed 30% with a very large number of reported
risk factors. Determinants of mortality beyond 1 year are rarely described. This study employs multiple
data linkages to examine mortality rates, risk factor proﬁles and age-speciﬁc excess mortality at intervals
from 30 days to 4 years.
Methods: Retrospective cohort study of linked administrative datasets describing hospital episodes,
residential aged care (RAC) admissions and date of death for 2552 Australian veterans and war widows
hospitalised for hip fracture in 2008–09. Associations between time to death and patient age, sex, pre-
fracture accommodation, fracture type, treatment options, selected comorbidities and complications
were tested in Cox proportional hazards models.
Results: In a population with mean age of 86.6 years (range 54–100 years), overall death rate was 11% at
30 days, 34% at 1 year, 47% at 2 years and 67% after 4 years. For males hospitalised from RAC 1-year mortality
was 72%, contrasting with 19% for females from the community. Risk of death within 1 year was increased
by male sex, increasing age, pre-fracture RAC residency, transfer to intensive care and coexistent cancer,
cardiac and renal failure, cerebrovascular disease and pressure ulcers. Patients selected for rehabilitation
had lower mortality rates. Patterns of determinants for mortality changed over time. Above-expected age-
speciﬁc mortality was sustained for 4 years except for males 90 years and older.
Conclusion: Pre-fracture RAC residence was the strongest determinant factor for mortality. Patients
selected for rehabilitation had lower mortality rates. The proﬁles of explanatory variables for death
altered with increasing time from the index fracture event.
 2015 Published by Elsevier Ltd.
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An increased mortality rate following hip fracture is beyond
dispute [1,2]. There is however a wide variation in reported
mortality rates at 30 days, 1 year and subsequently. International
population based studies report 1-year mortality rates between
22% and 31% [3–6], and higher in some smaller series [7]. Identiﬁed
risk factors for mortality are numerous, but the selection and
deﬁnition of determinant variables are both inconsistent [8].
Study datasets are derived from sources as diverse as single
hospitals, meta-analyses and national databases covering multiple* Corresponding author at: Department of Veterans’ Affairs, 300 Elizabeth Street,
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0020–1383/ 2015 Published by Elsevier Ltd.years [2,9,10]. Exclusion criteria, such as minimum age, coincident
injuries, pathological fractures, pre-fracture residential status or
non-surgical management are variably deﬁned and inconsistently
applied [11–14]. Mean age of subjects ranges from 80 to 87 years
[11–15]. Studies which identify pre-fracture residence consistently
show higher mortality in patients from supported living or
‘‘nursing homes’’ [12,16]. Differences in classiﬁcation of residential
aged care facilities present difﬁculties for comparing studies
[13–17]. Mortality rate after hip fracture relative to expected
population death rates is highest in the early months after injury,
but may persist for at least 10 years [2]. The excess of deaths
diminishes with time, more quickly for men than for women,
and for older survivors [2,6].
This study describes the mortality of a cohort of elderly hip
fracture patients over periods of up to 4 years. In addition to the
conventional risk factors of age, sex, fracture type and comorbid
diagnoses, the impacts of pre-fracture residential aged care status
Table 1
Deﬁnition and distribution of study variables for 2552 patients.
Item ICD-10-AM coding N %
Females 1592 62.4
Age group
<80 158 6.2
80–84 606 23.7
85–89 1114 43.7
90 674 26.4
Admitted from RAC 708 27.7
Fracture type
Cervical S720.1–S720.4 981 38.4
Trochanteric S720.5, S721.0, S721.1 1081 42.4
Subtrochanteric S722 110 4.3
Other, unspeciﬁed S720.0, S720.8 380 14.9
Rehabilitation Z50.8, Z50.9 1172 45.9
Surgery 2213 86.8
Internal ﬁxation 47519 981 38.4
Hemiarthroplasty 47522 1081 42.4
Primary hip replacement 49315, 49318 110 4.3
Other 47528, 49324,
49333, 49342
380 14.9
Intensive care 173 6.8
Comorbidities
Dementia F01–F03, F05.1, G30.9 574 22.5
Renal failure N18, N19 349 13.7
Cardiac failure I50 335 13.1
Cardiac ischaemia I20–I25 261 10.2
Diabetes E10–E14 247 9.7
Respiratory disease J40–J47 216 8.5
Cerebrovascular disease I60–I69 161 6.3
Malignancy C00–C99 161 6.3
Complications
Urinary tract infection N39 434 17.0
Pressure ulcer L89, L97 367 14.4
Anaemia D62, D64.9 366 14.3
Respiratory infection J13, J15–J18, J20–J22 254 10.0
Delirium F05 246 9.6
Surgical site infection T81.4, T84.5, T84.7 63 2.5
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the index hospitalisation are also examined. To our knowledge this
is the ﬁrst Australian study to report and analyse determinants of
hip fracture mortality in a substantial national cohort which
identiﬁes a large sample of aged care residents.
Methods
Patients were drawn from the Australian Department of
Veterans’ Affairs (DVA) Treatment Population which comprises
all clients receiving health services during the year in question.
Records for all service episodes carry a patient speciﬁc identifying
number, which facilitates linkage of datasets. For this study,
datasets for public and private hospital episodes, residential aged
care (RAC) admissions, and date of death were linked for all TPOP
members who were hospitalised for hip fracture (ICD-10-AM
S72.0-S72.2 inclusive) between 1 July 2008 and 30 June 2009 (the
index hospitalisation). Hospital episodes continuous with the
index admission date were concatenated to identify the total
continuous hospital stay for each patient. Second and subsequent
hospital admissions for hip fracture within the study year were
excluded from analyses. Patients with immediate pre-fracture RAC
residence (RAC patients) were identiﬁed from matching or
overlapping dates of discharge from RAC and hospital admission.
Patients who were not admitted directly from RAC were thereafter
described as ‘‘community patients’’. Further details of the linkage
processes are described in a previous publication [18].
Variable classes included in the dataset were: age, sex, fracture
type, hospital separation status, surgical procedures, intensive care
and rehabilitation episodes, comorbidities and complications. ICD-
10-AM codes in the hospital datasets were used to identify all
variables with the exception of intensive care episodes, which
were identiﬁed by service type. All coded items were identiﬁed
within the episode string for the index hospitalisation, with the
exception of comorbidities, sourced from primary or secondary
diagnoses for all hospital episodes in the study year, up to and
including the index admission. Surgical codes were included if
they were accompanied by one of the codes for hip fracture.
Rehabilitation codes were included whether treatment required
transfer to another hospital or transfer within the same hospital.
Fracture type was classiﬁed as cervical, trochanteric, subtro-
chanteric and ‘other’. Surgical procedures were grouped as internal
ﬁxation, hemiarthroplasty, total hip replacement and ‘other’.
Comorbid conditions considered to have potential impacts upon
mortality in this population were selected from the 1999 revision
of the Charlson Index [19,20] and included dementia, renal failure,
cardiac failure, ischaemic heart, chronic respiratory and cerebrovas-
cular diseases, diabetes and malignancy. Complications were skin
ulceration, delirium, post-haemorrhagic or unspeciﬁed anaemia,
plus urinary, lower respiratory and surgical site infections. All coding
items are listed in Table 1.
Statistical analyses
Time to death was calculated from the admission date of the
index hospitalisation.
Univariate analyses of study variables were assessed with
Kaplan–Meyer survival curves and log-rank testing. As it was
apparent from these analyses that the effects of some variables
altered with time, three separate multivariate Cox Proportional
Hazards models were ﬁtted for periods of 0–29 days, 30 days to
1 year and 1–2 years. Variables entered these models if P < 0.25
in univariate analysis and, remained in the ﬁnal model if P < 0.05
after backwards elimination. Interactions between the variables
of age-group, rehabilitation and RAC were tested but none reached
the required signiﬁcance standard of <0.01. Collinearity betweenexplanatory variables was discounted after testing Pearson correla-
tion coefﬁcients and variance inﬂation factors.
A standardised rate (MR) for males and females was calculated
for each of 4 years after the index admission. The reference
population was the aggregated DVA Treatment Population for 1 July
2009 to 30 June 2010 inclusive [21]. Comparative mortality was
then calculated by comparing, for males and females, MR in the
given year against that of the reference population. Patients aged
<70 years were excluded from these analyses due to small numbers
and inconsistent age ranges in this group. Comparisons of mortality
rates (MR) between this and other studies necessitated adjusting
for the older age and higher proportion of males in the DVA sample.
After adjusting male:female proportions to the DVA proﬁle, the
sex-speciﬁc rates were applied to the new sub-populations. If
these rates were unknown, a conservative assumption that male
MR = 1.5 times the female MR was made [22–24]. The resulting
number of deaths in the younger population was then multiplied by
1.05 [22,24], compounding for every year of difference in mean age.
All analyses were performed using SAS 9.3 (SAS Institute Inc;
Cary, NC) or Excel 2010 (Microsoft Corporation, Redmond, WA).
Ethics approval was granted by the DVA Human Research Ethics
Committee in December 2010 and renewed in December 2013
(Reference E010/030).
Results
The study population was 2552 DVA clients of whom 960
(37.6%) were males. Mean age was 86.6 (range 54–100 years) with
1788 patients (70.1%) being 85 years or older. (Table 1). Multiple
comorbidities were identiﬁed for 591 patients (23%) with 44%
having none of the listed conditions. Multiple complications were
Table 2
Mortality rates following hip fracture: by sex and age groups at time intervals to
two years.
Age group N 30
days (%)
90
days (%)
One
year (%)
Two
years (%)
Males
<85 240 28 (12) 44 (18) 74 (31) 103 (43)
85 720 140 (19) 217 (30) 330 (46) 426 (59)
All males 960 168 (18) 261 (27) 404 (42) 529 (55)
Females
<85 524 27 (5) 57 (11) 123 (23) 174 (33)
85 1068 90 (8) 187 (18) 337 (32) 493 (46)
All females 1592 117 (7) 244 (15) 460 (29) 667 (42)
All patients 2552 285 (11) 505 (20) 864 (34) 1196 (47)
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There were 708 patients (27.7%) admitted from RAC.
Mortality rates at four time intervals up to 2 years are shown in
Table 2. At 30 days after the index admission date 285 patients
(11%) had died, 222 of these without leaving hospital. By the end of
1 year, 864 patients (34%) had died. Barely half of all patients (53%)
survived to the end of the second year and only one-third were
alive after 4 years. At all listed time points the mortality rate for
males was signiﬁcantly higher (P < 0.001). Younger patients had
lower rates throughout (Table 2) with this trend being more
deﬁned for males. At 1 year, 10 of 49 males (20%) aged less than
80 years had died compared to 52% of 250 males aged 90 years or
older (P < 0.001). The corresponding rates for females were 24%
and 36% (P < 0.001).
Determinant factors for mortality
The spectrum of signiﬁcant factors for mortality varied across
time (Table 3; Fig. 1). In the ﬁrst 30 days, male sex, older age and
admission into intensive care were all associated with approxi-
mately twice the baseline mortality risk, and patients from RAC
had a 50% greater risk of dying. Patients selected for surgicalTable 3
Determinants of mortality: time intervals to 2 years following hip fracture.
<30 days 30–
HRa (95% CI) P HR 
Sex 1.9 (1.5–2.4) <0.001 1.3 
Age-group 0.002 
<80 Referent Refe
80–84 2.1 (0.9–4.9) 0.9 
85–89 2.4 (1.0–5.4) 1.0 
90 3.4 (1.5–7.7) 1.3 
RACb 1.5 (1.2–1.9) 0.001 3.4 
New RAC transferc 0.4 (0.2–0.8) 0.007 1.5 
Rehabilitation 0.1 (0.0–1.0) <0.001 0.6 
Surgery 0.4 (0.3–0.5) <0.001
Intensive care 1.9 (1.3–2.7) <0.001 1.6 
Comorbidities
Cancer 1.4 
Cardiac failure 1.6 (1.2 2.1) 0.003 1.6 
Ischaemic HD 1.5 (1.1–2.1) 0.017
Dementia 
Diabetesd
Renal disease 1.4 (1.2–1.6) <0.001 1.2 
Stroke 1.4 
Complications
UTI 0.4 (0.2–0.7) 0.001
Skin ulceration 1.3 
a HR = Hazard ratio.
b RAC = RAC occupancy immediately before fracture.
c Community patients transferred to RAC.
d Includes diabetes with complications.treatment were much less likely to die in the ﬁrst 30 days: only
11 of 1172 patients selected for rehabilitation died within the ﬁrst
30 days. Cardiac failure, non-AMI ischaemic heart disease and renal
disease all increased mortality risk by approximately 50%; a
diagnosis of urinary infection had apparent survival value.
Between 30 days and 1 year, the hazard ratios for sex and age
were smaller but the decline was not signiﬁcant. Pre-fracture
residence in RAC was the strongest determinant of mortality risk
across this period (Table 3). Admission into intensive care,
comorbid cardiac failure and renal disease continued to impart
a higher risk as earlier. Patients with cerebrovascular disease,
cancer or pressure ulcers also had increased risk of death between
30 days and 1 year after fracture.
Direct transfer of community patients from hospital to RAC
(new RAC transfer) was associated with higher mortality after
30 days (Table 3). At the end of 1 year 26.1% had died, compared
with 12.1% of patients discharged otherwise (P < 0.001).
In the second year following hip fracture, 335 patients died (20%
of 12-month survivors). Males were 40% more likely to die, and
risk for those aged 90 years or older was nearly three times that
for persons younger than 80 years. Patients from RAC were more
than three times more likely to die. Diabetes with complications,
cardiac failure, cancer and dementia were, in descending order,
associated with increased mortality, the latter having borderline
signiﬁcance (Table 3; Fig. 1).
From our analyses the main risk factors for mortality were age,
sex and prior RAC status. Fig. 2 shows survival curves for four
groups ordered by risk. In descending order these were: males
from RAC aged 85 years and older, females from RAC aged 85 years
and older, males from the community aged less than 85 years
and females from the community aged below 85. Females from
the community had 1-year mortality of 19% while 72% of males
from RAC had died. The addition of extra variables for age and
comorbidity further widened this disparity. Of 216 community
females aged <85 years with no comorbidities, 21 (10%) were dead
at 1 year, compared with 65 of 73 (89%) for RAC males aged 85 or
older with two or more comorbidities. RAC patients were slightly
older (mean age 88.1 vs 86.0 years, P < 0.001), with higher mean365 days 365–729 days
(95% CI) P HR (95% CI) P
(1.1–1.6) 0.001 1.4 (1.1–1.7) 0.006
0.007 0.004
rent Referent
(0.6–1.3) 2.0 (1.0–3.9)
(0.7–1.5) 2.3 (1.2–4.5)
(0.9–1.9) 2.9 (1.5–5.8)
(2.8–4.2) <0.001 3.3 (2.5–4.4) <0.001
(1.2–1.9) 0.002 1.6 (1.2–2.2) 0.002
(0.5–07) <0.001 0.7 (0.5–0.9) 0.001
(1.2–2.1) 0.002
(1.2–1.6) <0.001 1.5 (1.2 –1.8) <0.001
(1.3–2.0) <0.001 1.8 (1.3–2.4) <0.001
1.3 (1.0–1.7) 0.054
2.0 (1.4–3.1) 0.001
(1.1–1.3). 0.003
(1.0–1.8) 0.049
(1.1– 1.6) 0.008
Survival 30-720 days Survival 0-29 Days 
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Fig. 1. Survival curves in two time intervals for selected determinants of mortality.
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proportion of multiple comorbidities (29% vs 21%, P < 0.001) than
community patients.
Table 4 shows the mortality rates for males and females
standardised against the DVA Treatment Population for each of
4 years following fracture. Comparison rates are higher for all
4 years, being substantially higher in year 1, then essentially stable.
Males and females have similar ratios. Higher than expected
mortality was sustained for all 4 years for all patients except for
males aged 90 years and older in year 4.
Discussion
The mortality rates at 30 days, 90 days and 1 year in this study
were 11%, 20% and 34% respectively. These are higher rates than
reported in most other Australian and international studies
[6,11,24,25], but demographic factors probably account for much
of the differences. When adjusted to the age–sex distribution of
other Australian studies [22,25,26], the calculated 1-year mortality
rate for the study population was 29.3%. The factors which
determine mortality rates following hip fracture are numerous and
diverse: only the major elements from this study are discussed.
Patient demographics
Comparisons between mortality rates in different studies
should be drawn with care. Adjustment for differences in ageTable 4
Relative mortality rates (MR) following hip fracture in 2552 DVA clients.
Numbera Deathsb Actual
MRc
Expected
MRd
Comparative
MRe
Males
Year 1 939 388 0.413 0.125 3.3 (3.0–3.5)
Year 2 535 121 0.226 0.125 1.8 (1.5–2.1)
Year 3 411 96 0.234 0.125 1.9 (1.6–2.2)
Year 4 314 79 0.252 0.125 2.0 (1.6–2.4)
Females
Year 1 1583 434 0.274 0.086 3.2 (2.9–3.4)
Year 2 1125 201 0.179 0.086 2.1 (1.8–2.3)
Year 3 915 163 0.178 0.086 2.1 (1.8–2.4)
Year 4 745 149 0.200 0.086 2.3 (2.0–2.6)
a Survivors at commencement of year.
b Values are age-standardised against DVA Treatment Population July 2009–June
2012.
c MR for given year.
d MR for DVA Treatment Population July 2009–June 2012.
e Comparative MR = Actual MR / Expected MRand sex distributions, as deﬁned for this study, can substantially
alter crude rates. The Bureau of Health Information in New South
Wales reported 30-day mortality of 6.9% for public hospital
patients with surgical treatment for hip fracture [26]. Mean age
was 82.9 years, with 72.4% females. Adjustments for age and sex
resulted in a mortality rate of 8.6%, comparable with 9.3% for
surgical patients in the present study (P = 0.35). A tertiary hospital
in Newcastle NSW, reported a series with mean age of 83.5 years
and 73.7% females [22]. The reported 30-day mortality of 8.2%
equated to 10.3% after adjustment to the DVA demographics.
Register-based studies of large Danish, Swedish and Finnish
cohorts with similar demographics (mean ages 80.7–81.4 years,
females 72–74%) reported 1-year mortality rates of 29.3%, 23.9%
and 27.0% respectively. The 1-year mortality for the present study
would not exceed 26% with these demographic proﬁles, assuming
equivalence of other risk factors. It is noted for example that
patients admitted from RAC were excluded from the Finnish study,
while not speciﬁcally identiﬁed in the others [3,4,24].
Residential aged care
Admission from RAC was the most important single determi-
nant of mortality in this study. Other reports have conﬁrmed this,
although not in comprehensive multivariate analyses. An ortho-
geriatric service in Norway reported 1-year mortality of 46% (61%)
for 137 patients admitted from nursing homes compared with 14%
for the remaining 430 patients [15]. A Dutch study, in which
patients from RAC were older by 5 years, found 45% and 17% [12]
respectively. An Australian hospital study of 666 hip fracture
patients found 1-year mortality of 40% in patients from RAC with
an age-adjusted relative risk of 1.8 (95% CI 1.4–2.4): other potential
risk factors were not identiﬁed [16]. Adjusted HR values for RAC
patients of 1.6 at 30 days and 3.2 at 1 year, in other studies [5,15]
closely matched the values in our study. It is also noted that,
hip fracture increases mortality risk even within a cohort of
exclusively frail, institutionalised persons [27].
The higher mortality risk of RAC patients in the context of hip
fracture is only partially explained by the data of this study. RAC
residents in the atypical cohort of this study were signiﬁcantly older,
though by only 2 years and comorbidity was signiﬁcantly higher.
Three times more RAC patients have diagnosed dementia in these
data, but as discussed below this has marginal additional impact on
mortality in this study. RAC patients have shorter hospital stay,
much lower rates of transfer for hospital-based rehabilitation and
hospital survivors are discharged almost exclusively back to RAC
[28]. Details of physical functionality were not available but it is
noted that the Australian criteria for RAC admission equate with
substantial functional and/or cognitive incapacities [29].
Comorbidity
This study elected to describe the effect of individual comorbid
conditions on the assumption that clinicians are more likely to
identify and respond to a medical diagnosis than (even a validated)
calculated index. Eight of the 12 diagnoses identiﬁed in the
1999 modiﬁcation of the Charlson Index [19] were associated with
increased mortality for this study population at some time period.
Cardiac failure, cancer and renal impairment were most consis-
tently associated.
Comorbidities in hip fracture patients may be identiﬁed from
coded administrative databases, by physician assessment, or from
searches within clinical records or [5,14,16] with resulting wide
differences in detection rates. The reported prevalence of cardiac
failure ranges from 3.7% to 17% [5,30], while some studies conceal this
diagnosis within ‘cardiovascular disease’ [7,14] or omit it [30,31].
Of the 19 referenced studies which identify comorbidity, only three
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others use Charlson scores only [15,23,32]. Coincident dementia
is reported in rates ranging from 12.3% to 28.8% and is cited as
contributing to increased 30-day or longer-term mortality [10,22,
32]. Our study found that dementia, though much more frequent
in RAC patients, was not an independent risk factor across the ﬁrst
year when pre-fracture RAC residence or new RAC transfers
were identiﬁed in multivariate models. In the second year a
marginal association between dementia and mortality was identiﬁed
(Table 3).
Such inconsistencies in study design compromise the value of
comparisons between studies and meta-analyses in particular
[8]. The improving levels of compliance with data reporting in
the National Hip Fracture Database in the UK [34] – and the
consequent improvements in outcomes – suggest that standardi-
sation of datasets and analytical protocols may be both practical
and beneﬁcial. At least two algorithms for differentiating risk
status for hip fracture mortality have been validated [5,33]. These
are based upon data items which are readily available in the
clinical setting.
Comparative mortality
An extensive meta-analysis [2] showed that mortality risk was
as high as eight times that of control populations in the ﬁrst
3 months after injury and remained above threefold in the second
year. Thereafter rates declined slowly but remained signiﬁcant at
10 years. Males had higher relative mortality than females. Several
studies reported in a 2008 review conﬁrm that this higher
mortality diminishes in older patients [8]. Although age-standar-
dised death rates in this study tended to be higher for men for at
least 4 years, we could not conﬁrm that the degree of excess
mortality was greater for men.
Strengths and weaknesses
This study beneﬁtted from the capacity to link different
administrative datasets, in particular the matching of RAC
occupancy with dates of hospital admission and discharge. An
extensive list of comorbidities and clinical process options was
available in coded formats. The accuracy of Australian diagnostic
coding in such datasets is accepted as sufﬁcient to support valid
analyses of this nature [35,36].
Prevalence of individual comorbidites and complications did
not match the detection rates obtained from personal medical ﬁles
in some studies [15] but generally exceeded those reported from
an Australian tertiary hospital [29]. Other studies based on
administrative databases found lower rates for key comorbidities
in most instances [5,7,10]. Information on disease severity and pre-
fracture functional status was not available to further inform risk
status of our study. While pre- and post-fracture RAC occupancy
was accurately identiﬁed from our data, the exact residential status
of ‘non RAC’ or community patients was not available. The clear
statistical separation of results for these two residential groups
would, if anything, have been enhanced if community patients
included some with less than ideal health and physical capacity.
This higher age distribution and greater proportion of males in
this study has been recognised by reporting relevant values by age
and sex and by adjusting global mortality rates for age and sex.
Conclusion
Pre-fracture residential status is the strongest single determi-
nant of mortality after hip fracture: patients from RAC have three
times the 1-year mortality rate of those previously living
elsewhere in multivariate models. Male sex, increasing age, newtransfer to RAC and comorbid cardiac failure, cancer, respiratory
and renal disease are all associated with increased mortality at
1 and 2 years, while patients selected for rehabilitation have lower
rates. The use of data items routinely available during initial
hospital care can be combined to clearly deﬁne high and low risk
for subsequent mortality.
Knowledge of pre-fracture residential status is vital to the
interpretation of mortality rates following hip fracture. Acceptance
of a common protocol for measuring mortality risk would greatly
enhance the value of studies which describe outcomes for this
complex population.
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